Stock Scorecard



Stock Summary for Veracyte Inc (VCYT) - $31.32 as of 5/5/2025 9:27:58 PM EST

Total Score

12 out of 30

Safety Score

45 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VCYT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VCYT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VCYT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VCYT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VCYT (45 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VCYT

Ekso Bionics ( EKSO ) Reports Q1 Loss, Misses Revenue Estimates 5/5/2025 9:35:00 PM
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms - ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ ) , ARK Innovation ETF ( BATS:ARKK ) 4/26/2025 7:39:00 AM
Should You Continue to Hold Veracyte Stock in Your Portfolio? 4/17/2025 1:12:00 PM
International Growth Drives GMED Stock Amid Fierce Competition 4/14/2025 4:18:00 PM
Bruker Stock May Benefit Following Its Investment in Ridom GmbH 4/14/2025 12:24:00 PM
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? 4/11/2025 2:01:00 PM
Veracyte ( VCYT ) Just Overtook the 20-Day Moving Average 4/10/2025 1:35:00 PM
Strength Seen in Veracyte ( VCYT ) : Can Its 13.0% Jump Turn into More Strength? 4/10/2025 1:04:00 PM
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago 4/10/2025 12:30:00 PM
Should You Continue to Hold Bio-Rad Stock in Your Portfolio? 4/3/2025 1:00:00 PM

Financial Details for VCYT

Company Overview

Ticker VCYT
Company Name Veracyte Inc
Country USA
Description Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2024
Next Earnings Date 5/5/2025

Stock Price History

Last Day Price 31.32
Price 4 Years Ago 41.20
Last Day Price Updated 5/5/2025 9:27:58 PM EST
Last Day Volume 861,419
Average Daily Volume 982,129
52-Week High 47.32
52-Week Low 19.73
Last Price to 52 Week Low 58.74%

Valuation Measures

Trailing PE 98.39
Industry PE 215.65
Sector PE 37.03
5-Year Average PE -15.60
Free Cash Flow Ratio 10.20
Industry Free Cash Flow Ratio 27.27
Sector Free Cash Flow Ratio 29.42
Current Ratio Most Recent Quarter 4.73
Total Cash Per Share 3.07
Book Value Per Share Most Recent Quarter 15.12
Price to Book Ratio 2.08
Industry Price to Book Ratio 2.27
Sector Price to Book Ratio 21.93
Price to Sales Ratio Twelve Trailing Months 5.49
Industry Price to Sales Ratio Twelve Trailing Months 2.28
Sector Price to Sales Ratio Twelve Trailing Months 28.34
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 77,945,000
Market Capitalization 2,441,237,400
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 132.44%
Reported EPS 12 Trailing Months 0.31
Reported EPS Past Year 0.00
Reported EPS Prior Year 0.60
Net Income Twelve Trailing Months 24,138,000
Net Income Past Year 24,138,000
Net Income Prior Year -74,404,000
Quarterly Revenue Growth YOY 20.80%
5-Year Revenue Growth 29.93%
Operating Margin Twelve Trailing Months 6.62%

Balance Sheet

Total Cash Most Recent Quarter 239,087,000
Total Cash Past Year 239,087,000
Total Cash Prior Year 216,454,000
Net Cash Position Most Recent Quarter 238,012,000
Net Cash Position Past Year 238,277,000
Long Term Debt Past Year 810,000
Long Term Debt Prior Year 810,000
Total Debt Most Recent Quarter 1,075,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 1,175,966,000
Total Stockholder Equity Prior Year 1,044,102,000
Total Stockholder Equity Most Recent Quarter 1,175,966,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 63,809,000
Free Cash Flow Per Share Twelve Trailing Months 0.82
Free Cash Flow Past Year 63,809,000
Free Cash Flow Prior Year 34,261,000

Options

Put/Call Ratio 0.12
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.16
MACD Signal -0.33
20-Day Bollinger Lower Band 25.79
20-Day Bollinger Middle Band 36.51
20-Day Bollinger Upper Band 47.23
Beta 2.04
RSI 46.77
50-Day SMA 32.53
150-Day SMA 26.61
200-Day SMA 28.69

System

Modified 5/3/2025 12:44:56 PM EST